New pill offers hope for stubborn lung disease
NCT ID NCT07301320
Summary
This study is testing whether a new oral medication called epetraborole can help adults with a chronic and difficult-to-treat bacterial lung infection (Mycobacterium abscessus). Participants will take either the drug or a placebo pill daily for 12 weeks to see if it improves symptoms, clears the bacteria from the lungs, and is safe. The goal is to find a simpler, oral treatment option for this condition, which usually requires complex intravenous antibiotics.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM ABSCESSUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.